Patent court rules against Lilly in patent suit

Published: 2010-11-11 07:00:00

Updated: 2010-11-11 07:00:00

Korea’s patent court on November 5 dismissed claims by Eli Lilly, one of the world’s largest drug companies, in a patent lawsuit against Hanmi Pharm over its generic antipsychotic drug.

Zyprexa (olanzapine) is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar di...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK